TXLNA and pancreatic adenocarcinoma: Analysis based on TCGA data in LOGpc showed that the high TXLNA expression group had favourable OS (p=0.0175; HR: 0.5519; 95% CI: 0.338–0.9013; Figure 2(a)), DFI (p=0.0149; HR: 0.4971; 95% CI: 0.2832–0.8725; Figure 2(b)), DSS (p=0.05; HR: 0.5549; 95% CI: 0.3079–1.0001; Figure 2(c)), and PFI (p=0.0153; HR: 0.5515; 95% CI: 0.3409–0.8921; Figure 2(d)) for PAAD patients.